Invited speakers
Opening keynote presenter:
Prof Martin Michel, Professor of Pharmacology, Johannes Gutenberg University, Germany
 |
Martin C. Michel is a physician trained in experimental and clinical pharmacology in Essen (Germany) and San Diego (California). He headed the Nephrology and Hypertension Research Laboratory in Essen (1993-2002) and the Department of Pharmacology & Pharmacotherapy at the University of Amsterdam (The Netherlands, 2003-2011). Since 2011, he is the Global Head of Product and Pipeline Scientific Support at Boehringer Ingelheim. He has published more than 400 scientific articles, is the Editor-in-Chief of Naunyn-Schmiedeberg’s Archives of Pharmacology and also serves on the board of many pharmacological, physiological and urological journals. His research focusses on urogenital and cardiovascular pharmacology. |
British Pharmacological Society presenter:
Dr Ana Alfirevic- Senior Lecturer, University of Liverpool, UK
 |
My research over the last 10 years has been focused on molecular pharmacology and pharmacogenetics. I have been working on identification of genetic predisposing factors for adverse drug reactions including drug-induced hypersensitivity, hepatotoxicity and agranulocytosis. Collaborations include evidence synthesis with the Cochrane Collaboration Skin Group and systems biology projects in reproductive medicine and pregnancy. Currently, I lead a work package within the PREDICTION-ADR EU grant that aims at investigating predisposing genetic factors to statin-induced myopathy and angiotensin-converting-enzyme (ACE) inhibitor-induced angioedema utilizing next generation sequencing strategy. Additionally, I have been involved in public health research via the UK National Institute of Health Research Collaboration for Leadership in Applied Health Research and Care (CLAHRC), with the overarching ambition to tackle health inequalities. I am a co-lead for the Delivering Personalised Health and Care theme, which aims to implement genotype-guided warfarin dosing and introduce renal function monitoring into clinical practice using point-of-care devices. |
Japanese Pharmacological Society presenter:
Prof Yoshikatsu Kanai, Department of Bio-system Pharmacology, Osaka University Graduate School of Medicine, Japan
 |
Professor Yoshikatsu Kanai studied Medicine and obtained his Ph.D. degree at The University of Tokyo (Tokyo, Japan). He, then, worked as a research fellow in Renal Division at Brigham and Women’s Hospital and Harvard Medical School (Boston, U.S.A.). He was promoted as Professor of Pharmacology in Kyorin University School of Medicine (Tokyo, Japan) in 2001 and moved to Osaka University as Professor of Bio-system Pharmacology in 2007. He has worked on many types of transporters including those for sugars, amino acids, urate and organic anions/drugs and contributed to their molecular identification and revealing the pathophysiological relevance. His research is now directing toward the application of transporters to molecular target drug discovery. The renal glucose transporter SGLT2 that he found in 1994 has been successfully established as a target of anti-diabetic therapy. He is now focusing on amino acid transporters in cancers for the diagnosis and therapeutics. |
APSA Lecturer:
Prof Shane Desselle, Touro University California and Editor, Research in Social and Administrative Pharmacy
 |
Shane Desselle is Professor at Touro University, President of Applied Pharmacy Solutions, and formerly Dean at California Northstate University. He received his B.S. (Pharmacy) and Ph.D. (Pharmacy Administration) from University of Louisiana at Monroe. He began his career at Long Island University, then became Director of Assessment at Duquesne University, where he won University-level teaching and research awards. He then served as Associate Dean at University of Oklahoma. He co-edits Pharmacy Management: Essentials for All Practice Settings. He is founding editor of Research in Social & Administrative Pharmacy and has served on the editorial boards of JMCP, JAPhA, AJPE, and Remington: The Science and Practice of Pharmacy. Dr. Desselle has served on AACP’s Board of Trustees and on Boards of regional chapters of the Leukemia and Lymphoma Society and American Diabetes Association. He has published over 80 original research articles and has taught courses in social/behavioral pharmacy, research methods, and pharmacy management. |
ASCEPT Michael Rand Medal Lecturer:
Prof David Le Couteur, Centre for Education and Research on Ageing; The University of Sydney
 |
David Le Couteur is Professor of Geriatric Medicine at the University of Sydney and Director of the Centre for Education and Research on Ageing (CERA) at Concord Hospital. He is immediate past president of ASCEPT and has been a member of the Australian Drug Evaluation Committee, Pharmaceutical Benefits Advisory Committee and the Advisory Committee on the Safety of Medicines. He is secretary of the Clinical Division of the International Union for Basic and Clinical Pharmacology (IUPHAR) and was recipient of the American Society for Clinical Pharmacology and Therapeutics 2013 William B Abrams award for contribution to geriatric clinical pharmacology |
APSA Medal:
Prof Sanjay Garg BPharm, MPharm, PhD, MMgt, University of South Australia
 |
Sanjay Garg is Professor of Pharmaceutical Sciences at the School of Pharmacy and Medical Sciences and Director of the Centre for Pharmaceutical Innovation and Development (CPID), Sansom Institute, University of South Australia, Adelaide. He is responsible for the China Australia Centre for Health Science Research (CACHSR). Before joining UniSA in 2012, Sanjay acted as Deputy Head, School of Pharmacy, and Founding Chief Scientific Officer of AnQual GLP analytical laboratory at the University of Auckland, New Zealand. Sanjay leads a research team focusing on fundamental and translational aspects of conventional and novel drug delivery systems for human and veterinary applications, especially in the areas of microbicides, resistant infections and cancer targeting. A number of formulations from his laboratory have reached clinical stages and market. Sanjay has published 144 peer reviewed articles, 20 book chapters, several patents, and participated in over 200 conference presentations. He has edited a book on MCQs in Pharmaceutical Sciences, published by the Royal Pharmaceutical Society, UK. Sanjay served as an executive committee member for APSA and Board member for the International Society for Pharmaceutical Engineering (ISPE), Australasia affiliate. The Young Pharmacy Teacher of the year in 2002 and the Butland award for excellence in research supervision in 2007 are the honours, with which he has been honoured. |
Symposium speakers